Using multi-criteria decision analysis to appraise orphan drugs: a systematic review

Carlotta Friedmann, Pierre Levy, Paul Hensel, Mickael Hiligsmann

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)135-146
Number of pages12
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume18
Issue number2
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Multi-criteria decision analysis
  • MCDA
  • orphan drugs
  • rare diseases
  • reimbursement
  • appraisal
  • systematic review
  • HEALTH TECHNOLOGY-ASSESSMENT
  • PRACTICES TASK-FORCE
  • RARE DISEASES
  • ANALYSIS MCDA
  • REIMBURSEMENT SYSTEMS
  • EVALUATING TREATMENTS
  • EVIDEM FRAMEWORK
  • CRITERIA
  • CARE
  • CONTEXT

Cite this